𝔖 Bobbio Scriptorium
✦   LIBER   ✦

p53 Mutations Occur in Clinical, but Not Latent, Human Prostate Carcinoma

✍ Scribed by Konishi, Noboru ;Hiasa, Yoshio ;Hayashi, Isao ;Matsuda, Hirofumi ;Tsuzuki, Toshihide ;Ming, Tao ;Kitahori, Yoshiteru ;Shiraishi, Taizo ;Yatani, Ryuichi ;Shimazaki, Jun

Book ID
108581022
Publisher
Wiley (Blackwell Publishing)
Year
1995
Tongue
English
Weight
749 KB
Volume
86
Category
Article
ISSN
0910-5050

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Abnormal p53 expression is rare in clini
Abnormal p53 expression is rare in clinically localized human prostate cancer: Comparison between immunohistochemical and molecular detection of p53 mutations
✍ Mottaz, Alain E.; Markwalder, Regula; Fey, Martin F.; Klima, Irena; Merz, Vincen πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 180 KB πŸ‘ 3 views

## BACKGROUND. We assessed the frequency and molecular basis of p53 mutations in clinically localized prostatic adenocarcinoma. METHODS. Prostate specimens were examined from 100 patients with clinically localized prostatic adenocarcinoma and 13 patients with benign prostatic hyperplasia (BPH). Mu

Aflatoxin-B exposure does not lead to p5
Aflatoxin-B exposure does not lead to p53 mutations but results in enhanced liver cancer of Hupki (human p53 knock-in) mice
✍ Wei-Min Tong; Ming-Kei Lee; Dominique Galendo; Zhao-Qi Wang; Kanaga Sabapathy πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 366 KB

## Abstract Hepatocellular carcinoma (HCC) is a common human malignancy that is often associated with risk factors such as aflatoxin‐B~1~ (AFB~1~) exposure and Hepatitis‐B virus infection in developing countries. There is a strong correlation between these risk factors and mutation of the tumor‐sup